Belite Bio Inc ADR (BLTE): Next-Year EPS Estimate 126.52%
As of 2026-06-11, Belite Bio Inc ADR (BLTE) has a next-year EPS growth estimate of 126.52%.
On 2026-05-26, analyst consensus for BLTE's next-year EPS growth shifted from 135.80% to 126.52% — a negative change of 9.28 percentage points. The revised estimate has been sustained across 13 subsequent trading sessions. Current-year growth is projected at -37.93%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 126.52%
- EPS growth this year
- -37.93%
- EPS next quarter (est)
- -$0.75
- Last price
- $136.85
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 126.52% | -37.93% | -$0.75 | $136.85 |
| 2026-06-10 | 126.52% | -37.93% | -$0.75 | $136.62 |
| 2026-06-09 | 126.52% | -37.93% | -$0.75 | $141.42 |
| 2026-06-08 | 126.52% | -37.93% | -$0.75 | $139.63 |
| 2026-06-07 | 126.52% | -37.93% | -$0.75 | $143.35 |
| 2026-06-04 | 126.52% | -37.93% | -$0.75 | $144.46 |
| 2026-06-03 | 126.52% | -37.93% | -$0.75 | $137.23 |
| 2026-06-02 | 126.52% | -37.93% | -$0.75 | $134.93 |
| 2026-06-01 | 126.52% | -37.93% | -$0.75 | $147.00 |
| 2026-05-31 | 126.52% | -37.93% | -$0.75 | $144.18 |
| 2026-05-28 | 126.52% | -37.93% | -$0.75 | $148.00 |
| 2026-05-27 | 126.52% | -37.93% | -$0.75 | $142.09 |
| 2026-05-26 | 126.52% | -37.93% | -$0.75 | $142.01 |
| 2026-05-25 | 135.80% | -38.76% | -$0.77 | $137.30 |
| 2026-05-24 | 135.80% | -38.76% | -$0.77 | $137.30 |
| 2026-05-21 | 135.80% | -38.76% | -$0.77 | $144.25 |
| 2026-05-20 | 144.57% | 5.78% | -$0.66 | $143.36 |
| 2026-05-19 | 144.57% | 5.78% | -$0.63 | $139.70 |
| 2026-05-18 | 144.57% | 5.78% | -$0.63 | $142.90 |
| 2026-05-17 | 144.57% | 5.78% | -$0.63 | $143.00 |
| 2026-05-14 | 144.57% | 5.78% | -$0.63 | $149.95 |
| 2026-05-13 | 144.57% | 5.78% | -$0.63 | $154.22 |
| 2026-05-12 | 144.57% | 5.78% | -$0.63 | $155.54 |
| 2026-05-11 | 144.57% | 5.78% | -$0.63 | $151.97 |
| 2026-05-10 | 144.57% | 5.78% | -$0.63 | $154.88 |
| 2026-05-07 | 144.57% | 5.78% | -$0.63 | $156.00 |
| 2026-05-06 | 144.57% | 5.78% | -$0.63 | $156.21 |
| 2026-05-05 | 144.57% | 5.78% | -$0.63 | $154.38 |
| 2026-05-04 | 144.57% | 5.78% | -$0.63 | $154.51 |
| 2026-05-03 | 144.57% | 5.78% | -$0.63 | $154.85 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Belite Bio Inc ADR's next-year EPS growth estimate?▾
As of 2026-06-11, Belite Bio Inc ADR (BLTE) has a next-year EPS growth estimate of 126.52%, based on analyst consensus.
When was the latest EPS estimate revision for BLTE?▾
The most recent revision occurred on 2026-05-26, when analysts adjusted the next-year EPS growth estimate from 135.80% to 126.52%.
What sector and industry does Belite Bio Inc ADR belong to?▾
Belite Bio Inc ADR operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. BLTE appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Belite Bio Inc ADR (BLTE) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports